H.C. Wainwright Reiterates Buy Rating on Disc Medicine (iRON)

October 28, 2024 7:28 AM EDT Send to a Friend
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $70.00 price target on Disc Medicine (NASDAQ: iRON).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login